Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 165-171, January 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galy, B.
Right arrow Articles by Prats, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galy, B.
Right arrow Articles by Prats, H.
[Cancer Research 59, 165-171, January 1, 1999]
© 1999 American Association for Cancer Research


Molecular Biology and Genetics

Cell Transformation Results in the Loss of the Density-dependent Translational Regulation of the Expression of Fibroblast Growth Factor 2 Isoforms1

Bruno Galy, Arlette Maret, Anne-Catherine Prats and Hervé Prats2

Institut National de la Santé et de la Recherche Médicale U397, Endocrinologie et Communication Cellulaire, Institut Fédératif de Recherche Louis Bugnard, Centre Hospitalier Regional Rangueil, 31403 Toulouse Cedex 04, France

Alternative initiation of translation at three CUG and one AUG start codons leads to the synthesis of four isoforms of fibroblast growth factor 2 (FGF-2) that have distinct intracellular localizations and affect the cell phenotype differently. We show here that the expression of FGF-2 CUG-initiated isoforms decreases in a cell-density-dependent manner in normal human skin fibroblasts (HSFs) concomitantly with the FGF-2 mRNA level. In contrast, CUG-initiated FGF-2 expression is constitutive in SK-HEP-1 cells and in HSFs transformed with SV40 large T antigen. Cell transfection using a plasmid containing the FGF-2 mRNA leader fused to chloramphenicol acetyl transferase demonstrated that up-regulation of the CUG codons depends on cis-elements located in this leader. Furthermore, UV cross-linking experiments revealed a correlation between CUG codons utilization and the binding of several proteins to the mRNA leader. On the basis of the presence of an internal ribosome entry site (IRES) in the FGF-2 mRNA, we used bicistronic vectors to transfect normal and transformed cells. The density-dependent regulation in normal HSFs was cap-dependent, whereas the constitutive CUG-initiated FGF-2 expression in transformed cells occurred essentially by an IRES-dependent mechanism. Unexpectedly, the use of the AUG start codon occurred exclusively by internal entry, which suggests the presence of a second independent IRES in the FGF-2 mRNA that would be constitutive. A study of the eIF-4E levels and of the 4E-BP1 phosphorylation state at increasing cell densities showed a decrease of the eIF-4E level, concomitant with 4E-BP1 dephosphorylation in normal cells but not in transformed cells. These data point out a complex mechanism for the regulation of FGF-2 isoforms expression involving both the cap-dependent and the cap-independent initiation of translation and favor a positive role of CUG-initiated FGF-2 in cellular proliferation and transformation.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Bonnal, F. Pileur, C. Orsini, F. Parker, F. Pujol, A.-C. Prats, and S. Vagner
Heterogeneous Nuclear Ribonucleoprotein A1 Is a Novel Internal Ribosome Entry Site trans-Acting Factor That Modulates Alternative Initiation of Translation of the Fibroblast Growth Factor 2 mRNA
J. Biol. Chem., February 11, 2005; 280(6): 4144 - 4153.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Martineau, C. Le Bec, L. Monbrun, V. Allo, I.-M. Chiu, O. Danos, H. Moine, H. Prats, and A.-C. Prats
Internal Ribosome Entry Site Structural Motifs Conserved among Mammalian Fibroblast Growth Factor 1 Alternatively Spliced mRNAs
Mol. Cell. Biol., September 1, 2004; 24(17): 7622 - 7635.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
A. Nieto, M. A. Sanchez, E. Martinez, and E. Rollan
Immunohistochemical Expression of p53, Fibroblast Growth Factor-b, and Transforming Growth Factor-{alpha} in Feline Vaccine-associated Sarcomas
Vet. Pathol., November 1, 2003; 40(6): 651 - 658.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. C. Morrish and M. G. Rumsby
The 5' Untranslated Region of Protein Kinase C{delta} Directs Translation by an Internal Ribosome Entry Segment That Is Most Active in Densely Growing Cells and during Apoptosis
Mol. Cell. Biol., September 1, 2002; 22(17): 6089 - 6099.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Wang and K. Pantopoulos
Conditional Derepression of Ferritin Synthesis in Cells Expressing a Constitutive IRP1 Mutant
Mol. Cell. Biol., July 1, 2002; 22(13): 4638 - 4651.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Créancier, P. Mercier, A.-C. Prats, and D. Morello
c-myc Internal Ribosome Entry Site Activity Is Developmentally Controlled and Subjected to a Strong Translational Repression in Adult Transgenic Mice
Mol. Cell. Biol., March 1, 2001; 21(5): 1833 - 1840.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
L. Van den Berghe, H. Laurell, I. Huez, C. Zanibellato, H. Prats, and B. Bugler
FIF [Fibroblast Growth Factor-2 (FGF-2)-Interacting-Factor], a Nuclear Putatively Antiapoptotic Factor, Interacts Specifically with FGF-2
Mol. Endocrinol., November 1, 2000; 14(11): 1709 - 1724.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
L. Creancier, D. Morello, P. Mercier, and A.-C. Prats
Fibroblast Growth Factor 2 Internal Ribosome Entry Site (IRES) Activity Ex Vivo and in Transgenic Mice Reveals a Stringent Tissue-specific Regulation
J. Cell Biol., July 11, 2000; 150(1): 275 - 281.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Touriol, A. Morillon, M.-C. Gensac, H. Prats, and A.-C. Prats
Expression of Human Fibroblast Growth Factor 2 mRNA Is Post-transcriptionally Controlled by a Unique Destabilizing Element Present in the 3'-Untranslated Region between Alternative Polyadenylation Sites
J. Biol. Chem., July 23, 1999; 274(30): 21402 - 21408.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Ronsin, V. Chung-Scott, I. Poullion, N. Aknouche, C. Gaudin, and F. Triebel
A Non-AUG-Defined Alternative Open Reading Frame of the Intestinal Carboxyl Esterase mRNA Generates an Epitope Recognized by Renal Cell Carcinoma-Reactive Tumor-Infiltrating Lymphocytes In Situ
J. Immunol., July 1, 1999; 163(1): 483 - 490.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Touriol, M. Roussigne, M.-C. Gensac, H. Prats, and A.-C. Prats
Alternative Translation Initiation of Human Fibroblast Growth Factor 2 mRNA Controlled by Its 3'-Untranslated Region Involves a Poly(A) Switch and a Translational Enhancer
J. Biol. Chem., June 16, 2000; 275(25): 19361 - 19367.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.